2m 2m 2m 2m 2m 2m 2m
Haleon Sp ADR (HLN)
NYSE
$10.03+$0.03 (+0.26%)
Price as of Aug 21, 2026 8:00 PM EDT- $44.0BMarket Cap
- 3.89%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Haleon Sp ADR (HLN)
$10.03+$0.03 (+0.26%)
HLN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.00 | ||
Change | +$0.13 (+1.32%) | ||
Open | $9.91 | ||
High | $10.03 | ||
Low | $9.89 | ||
Previous Close | $9.87 | ||
Volume | 8,117,854 | ||
30-Day Average Volume | 10,252,431 | ||
1-Week Change | 3.09% | ||
1-Month Change | 1.47% | ||
1-Year Change | 3.89% | ||
3-Year Change | 28.56% | ||
5-Year Change | -56.85% | ||
Fundamentals | |||
Shares Outstanding | 4.4B | ||
Total Assets | $32.6B | ||
Market Cap | $44.0B | ||
Enterprise Value | $42.7B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 3.21% | ||
Trailing Annual Dividend Yield | 1.97% | ||
Ex-Dividend Date | 08/14/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield